← Back to markets
CRISPR Therapeutics
CRSP · Health Care · Biotechnology
$59.45-0.61%
RS +20.9
Returns
| 7D | +10.8% |
| 1M | +24.2% |
| 3M | +25.7% |
| 6M | +11.8% |
| YTD | +14.1% |
| 1Y | +3.9% |
About CRISPR Therapeutics
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award (FOYA)…